Skip to main content
. 2024 Oct 10;104:41984. doi: 10.2340/actadv.v104.41984

Fig. 1.

Fig. 1

Dupilumab treatment in the present patients presenting with bullous pemphigoid and P-P keratoderma. The skin lesions are shown before (patient 1: panels A, C; patient 2: panels E, G, I, M) and after (patient 1: panels B and D; patient 2: panels F, H, L, N) dupilumab treatment. Note the marked clinical improvement in both two cases